Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  YOUNG JOHN D
2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2012
3. Issuer Name and Ticker or Trading Symbol
PFIZER INC [PFE]
(Last)
(First)
(Middle)
PFIZER INC.-CORP. SECRETARY, 235 EAST 42ND ST.
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Business Unit President
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

NEW YORK, NY 10017
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 66,539
D
 
Common Stock 1,215
I
By Trustee under the Pfizer Share Ownership Plan

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy)   (1) 02/21/2017 Common Stock 41,700 $ 25.87 D  
Employee Stock Option (right to buy)   (1) 02/22/2016 Common Stock 31,500 $ 26.2 D  
Employee Stock Option (right to buy)   (1) 02/23/2015 Common Stock 21,600 $ 26.2 D  
Employee Stock Option (right to buy)   (1) 02/26/2013 Common Stock 22,950 $ 29.33 D  
Employee Stock Option (right to buy)   (1) 02/25/2014 Common Stock 29,300 $ 37.15 D  
Stock Appreciation Rights 02/26/2014(2) 02/26/2014(2) Common Stock 39,677 $ 12.7 D  
Stock Appreciation Rights 02/25/2015(2) 02/25/2015(2) Common Stock 49,364 $ 17.69 D  
Stock Appreciation Rights 12/31/2014(2) 12/31/2014(2) Common Stock 26,767 $ 18.19 D  
Stock Appreciation Rights 02/24/2016(2) 02/24/2016(2) Common Stock 52,570 $ 18.9 D  
Stock Appreciation Rights 02/24/2018(3) 02/24/2018(3) Common Stock 43,520 $ 18.9 D  
Stock Appreciation Rights 02/23/2017(2) 02/23/2017(2) Common Stock 51,578 $ 21.03 D  
Stock Appreciation Rights 02/23/2019(3) 02/23/2019(3) Common Stock 43,724 $ 21.03 D  
Stock Appreciation Rights 02/28/2013(2) 02/28/2013(2) Common Stock 23,135 $ 22.55 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
YOUNG JOHN D
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
NEW YORK, NY 10017
      Business Unit President  

Signatures

Lawrence A. Fox, by power of atty., for John D. Young 06/08/2012
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These options are fully exercisable.
(2) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
(3) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.
 
Remarks:
poajy12.htm

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.